144 patients underwent combined gastroenteroscopy
Conditions
Interventions
control group (propofol group) :Administration of fentanyl and propofol
observation group (rimazole toluenesulfonate group):Administration of fentanyl and remitazolam toluenesulfonate
Sponsors
Shaoxing people's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) ASAI-II; 2)BMI18~30kg/m2 3) Underwent combined gastroenteroscopy (gastroscopy first, followed by enteroscopy) 4) Age: 18-60 years
Exclusion criteria
Exclusion criteria: 1) Patients with long-term use of psychotropic drugs and cognitive impairment; 2) Persons suffering from infectious diseases; 3) Those who are allergic to remazolam toluenesulfonate and propofol; 4) Patients assessed as difficult airway: modified Markov score grade III or above; 5) Pregnant and lactating patients; 6) Recent birth planners; 7) Those who have a serious history of alcoholism; 8) Those who have participated in any clinical trial within 3 months; 9) Patients who refused to participate in this trial study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of hypotension;Incidence of hypoxemia;the onset time of sedation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Recovery time;Satisfaction of gastroscope doctors;Dosage of anesthetic drugs;The cost of narcotic drugs used;Injection pain;Other related complications; | — |
Countries
China
Contacts
Public ContactDongliang Chen
Outcome results
None listed